Contact
QR code for the current URL

Press release Box-ID: 972452

Gerresheimer AG Klaus-Bungert-Straße 4 40468 Düsseldorf, Germany http://www.gerresheimer.de
Contact Mr Jens Kürten +49 211 6181250
Company logo of Gerresheimer AG

Gerresheimer at CPhl Middle East & Africa: Innovative and secure packaging for pharmaceuticals

(PresseBox) (Düsseldorf / Abu Dhabi (VAE), )
Based at booth D11 in Hall 1, Gerresheimer’s presence at CPhl Middle East & Africa – held from September 16 to 18 in Abu Dhabi (ADNEC) – will focus on micro pumps. Sensile Medical, a company of the Gerresheimer Group, developed for EVER Pharma under the brand name D-mine®, this wearable micro-infusion pump. It recently received European CE certification and it has already been launched in several European countries.

The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-to-day lives.

SenseCore – reliable function with a distinctive design
“Gerresheimer specializes in the safe storage and administration of all kinds of medication,” says Ingo Waschulewski, Business Development Manager of Sensile Medical, expert in SenseCore micro pump technology. With SenseCore micro pump technology, Sensile Medical ensures the safe, simple, and precise administration of liquid drugs by the patient themselves at home or on the move, and always with absolute reliability. Our injection aids are impressively simple and discreet to use and the patient does not see the needle, making it suitable for all manner of different applications. The modular and flexible platform family shows a distinctive and now Good Design as recently awarded - developed by the British agency Team Consulting for Sensile Medical.

Irradiation of plastic dropper bottles for ophthalmic and nasal
With the irradiation service Gerresheimer wants to make life easier for its customers when it comes to procuring their dropper bottle. By treating the products with gamma radiation Gerresheimer adds in an important work step before filling. Therefore the company selected, recognized,. It and certified partners. The chosen partner companies have the requisite certification in accordance with ISO standards 11137, 11737, and 13004. The benefits of this service speak for themselves: Gerresheimer is assuming responsibility for handling this work step from start to finish, including transport to the irradiation company, monitoring and inspecting its work, and delivering to the location specified by the customer. The in-spection processes also involve physically and chemically testing the product characteristics after irradiation. Gerresheimer regulates the vali-dation and revalidation of the entire process, helping to reduce costs for the customer.

Gerresheimer – the pharmaceutical glass specialist
Gerresheimer produces glass containers for medications in America, Europe, India, and China in accordance with uniform global standards. The products available range from simple tablet jars to sterile injection vials made of moulded or tubular glass. With the Gx Elite vials, Gerresheimer is setting new standards for type I vials made from borosilicate glass. They are the result of comprehensive optimization of the conversion process, removing all risks that can lead to product defects during manufacturing. Above all else, it prevents any glass-to-glass or glass-to-metal contact from when the tubular glass is made right through to the final packaging of the vials.

Gx® is a registered trademarks of the Gerresheimer Group.

All products of the Gerresheimer Group

Gerresheimer AG

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With plants in Europe, America, and Asia, the company generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2022, All rights reserved

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.